Target intelligence / Profile preview

Vacuolar-type H+-translocating ATPase (V-ATPase)

Target
V-ATPase
Molecular classification
Enzyme, Proton transporter, Rotary ATPase
01

Overview

Vacuolar-type H+-translocating ATPase (V-ATPase) is a large, multi-subunit rotary proton pump complex found in the membranes of intracellular organelles and the plasma membrane of specialized cells. It is composed of two main regions: the peripheral V1 domain, responsible for ATP hydrolysis, and the integral V0 domain, responsible for proton translocation across membranes[1][2][3]. V-ATPases play a fundamental role in acidifying various intracellular compartments—such as endosomes, lysosomes, and secretory vesicles—which is critical for protein degradation, receptor-mediated endocytosis, and neurotransmitter loading[2][3]. The complex is also essential in various differentiated cells for physiological processes such as bone resorption, urinary acidification, and tumor cell invasion[2]. V-ATPase dysfunction is associated with a spectrum of human diseases, including cancer, osteopetrosis, renal tubular acidosis, and sensorineural deafness[1][2]. Several natural and synthetic inhibitors target V-ATPase and are under investigation as potential anticancer or antimicrobial agents[2]. Key therapeutic challenges involve selective targeting to avoid systemic disruption of vital pH regulatory processes.

Other names
Vacuolar H+-ATPaseV-ATPaseVacuolar ATPaseVacuolar proton pumpV-type ATPase
02

Mechanism of action

Inhibition of ATP hydrolysis Blockade of proton translocation Disruption of organelle acidification Prevention of lysosomal/autophagic function in cancer

03

Biological functions

Acidification of intracellular compartmentsProton transport across membranesEndocytosis and vesicle traffickingBone resorptionUrinary acidificationSperm maturationTumor cell invasion
04

Disease associations

CancerOsteopetrosisRenal tubular acidosisDeafness (sensorineural)Infection (facilitates viral and bacterial entry)Other (metabolic and lysosomal disorders)
05

Safety considerations

Broad physiological importance: inhibition may affect essential functions in non-target tissuesRisk of disrupting pH homeostasis in kidneys, bone, and brainPotential for hearing loss or renal dysfunction
06

Interacting drugs

Bafilomycin A1

4 more in the full profile.

07

Biomarkers

Upregulation in tumors (e.g. breast, prostate, pancreatic cancers)Mutations in subunit genes (diagnostic for osteopetrosis or distal renal tubular acidosis)Increased V-ATPase activity in metastatic tissue

Beyond the preview

Go deeper on Vacuolar-type H+-translocating ATPase (V-ATPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolar-type H+-translocating ATPase (V-ATPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call